New York State Common Retirement Fund
JAZZ icon

New York State Common Retirement Fund’s Jazz Pharmaceuticals JAZZ Stock Holding History

New York State Common Retirement Fund’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73M Buy
32,094
+400
+1% +$87.6K 0.01% 896
2026
Q1 		$5.99M Sell
31,694
-135
-0.4% -$23.6K 0.01% 946
2025
Q4 		$5.41M Sell
31,829
-18,382
-37% -$2.82M 0.01% 1005
2025
Q3 		$6.62M Sell
50,211
-185
-0.4% -$22.2K 0.01% 941
2025
Q2 		$5.35M Hold
50,396
– – 0.01% 1045
2025
Q1 		$6.26M Sell
50,396
-3,877
-7% -$506K 0.01% 945
2024
Q4 		$6.68M Sell
54,273
-2,857
-5% -$337K 0.01% 973
2024
Q3 		$6.36M Sell
57,130
-8,707
-13% -$954K 0.01% 999
2024
Q2 		$7.03M Buy
65,837
+2,026
+3% +$223K 0.01% 971
2024
Q1 		$7.68M Sell
63,811
-32,371
-34% -$3.97M 0.01% 927
2023
Q4 		$11.8M Sell
96,182
-13,404
-12% -$1.67M 0.02% 752
2023
Q3 		$14.2M Sell
109,586
-2,386
-2% -$318K 0.02% 664
2023
Q2 		$13.9M Sell
111,972
-1,074
-1% -$145K 0.02% 729
2023
Q1 		$16.5M Buy
113,046
+3,093
+3% +$458K 0.02% 654
2022
Q4 		$17.5M Buy
109,953
+1,615
+1% +$237K 0.02% 619
2022
Q3 		$14.4M Sell
108,338
-161
-0.1% -$24.5K 0.02% 672
2022
Q2 		$16.9M Sell
108,499
-2,005
-2% -$309K 0.02% 633
2022
Q1 		$17.2M Sell
110,504
-660
-0.6% -$95.8K 0.02% 709
2021
Q4 		$14.2M Sell
111,164
-2,423
-2% -$318K 0.01% 839
2021
Q3 		$14.8M Buy
113,587
+7,471
+7% +$1.13M 0.02% 821
2021
Q2 		$18.9M Buy
106,116
+27,317
+35% +$4.73M 0.02% 708
2021
Q1 		$13M Sell
78,799
-23,400
-23% -$3.85M 0.01% 839
2020
Q4 		$16.9M Sell
102,199
-11,390
-10% -$1.7M 0.02% 706
2020
Q3 		$16.2M Sell
113,589
-17,630
-13% -$2.19M 0.02% 675
2020
Q2 		$14.5M Buy
131,219
+300
+0.2% +$33.2K 0.02% 717
2020
Q1 		$13.1M Buy
130,919
+20,020
+18% +$2.59M 0.02% 680
2019
Q4 		$16.6M Sell
110,899
-3,500
-3% -$476K 0.02% 741
2019
Q3 		$14.7M Sell
114,399
-13,363
-10% -$1.79M 0.02% 783
2019
Q2 		$18.2M Sell
127,762
-13,337
-9% -$1.79M 0.02% 697
2019
Q1 		$20.2M Sell
141,099
-24,427
-15% -$3.19M 0.03% 645
2018
Q4 		$20.5M Sell
165,526
-200
-0.1% -$29.7K 0.03% 571
2018
Q3 		$27.9M Buy
165,726
+950
+0.6% +$163K 0.03% 539
2018
Q2 		$28.4M Buy
+164,776
New +$26.9M 0.04% 513
2017
Q2 		– Sell
-15,111
Closed -$2.19M – 3211
2017
Q1 		$2.19M Buy
+15,111
New +$1.97M ﹤0.01% 1611
2016
Q4 		– Sell
-36,126
Closed -$4.39M – 3132
2016
Q3 		$4.39M Sell
36,126
-174,090
-83% -$23.5M 0.01% 1276
2016
Q2 		$29.7M Buy
210,216
+1,857
+0.9% +$274K 0.04% 447
2016
Q1 		$27.2M Buy
208,359
+12,850
+7% +$1.6M 0.04% 465
2015
Q4 		$27.5M Buy
195,509
+7,310
+4% +$1.01M 0.04% 462
2015
Q3 		$25M Buy
188,199
+62,196
+49% +$10.7M 0.04% 486
2015
Q2 		$22.2M Buy
126,003
+73,124
+138% +$13.1M 0.03% 552
2015
Q1 		$9.14M Sell
52,879
-15,895
-23% -$2.73M 0.01% 922
2014
Q4 		$11.3M Sell
68,774
-250
-0.4% -$41.5K 0.02% 823
2014
Q3 		$11.1M Buy
69,024
+39,053
+130% +$6M 0.02% 847
2014
Q2 		$4.41M Buy
29,971
+26,954
+893% +$3.74M 0.01% 1322
2014
Q1 		$418K Sell
3,017
-7,920
-72% -$1.19M ﹤0.01% 1940
2013
Q4 		$1.38M Hold
10,937
– – ﹤0.01% 1752
2013
Q3 		$1.01M Buy
10,937
+9,837
+894% +$794K ﹤0.01% 1753
2013
Q2 		$76K Buy
+1,100
New +$67.2K ﹤0.01% 1805

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

New York State Common Retirement Fund's JAZZ Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Jazz Pharmaceuticals (JAZZ) stake by 1.3% in Q2 2026, buying an estimated $87.6K and bringing the position to 32,094 shares worth $7.73M. The position accounts for 0.01% of the portfolio, ranked #896.

New York State Common Retirement Fund first reported a position in JAZZ in Q2 2013 and has held it in 48 quarters since. The position peaked at $29.7M in Q2 2016. 231 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • New York State Common Retirement Fund held 32,094 shares of Jazz Pharmaceuticals worth $7.73M as of Q2 2026.
  • New York State Common Retirement Fund bought 400 Jazz Pharmaceuticals shares in Q2 2026, an estimated $87.6K.
  • Jazz Pharmaceuticals made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #896 holding.
  • New York State Common Retirement Fund first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • New York State Common Retirement Fund's Jazz Pharmaceuticals position peaked at $29.7M in Q2 2016.
  • 231 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.